Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Aims To Eliminate Most Nicotine From Cigarettes
The Biden administration said Tuesday it plans to develop a rule requiring tobacco companies to reduce nicotine levels in cigarettes sold in the United States to minimally or nonaddictive levels, an effort that, if successful, could have an unprecedented effect in slashing smoking-related deaths and threaten a politically powerful industry. The initiative was included in the administration鈥檚 鈥渦nified agenda,鈥 a compilation of planned federal regulatory actions released twice a year. The spring agenda was released Tuesday. (McGinley, 6/21)
The plan, unveiled Tuesday as part of the administration鈥檚 agenda of regulatory actions, likely wouldn鈥檛 take effect for several years. The Food and Drug Administration plans to publish a proposed rule in May 2023, though the agency cautioned that date could change. Then the agency would invite public comments before publishing a final rule. Tobacco companies could then sue, which could further delay the policy鈥檚 implementation. 鈥淣icotine is powerfully addictive,鈥 FDA Commissioner Robert Califf said in a statement Tuesday. 鈥淟owering nicotine levels to minimally addictive or non-addictive levels would decrease the likelihood that future generations of young people become addicted to cigarettes and help more currently addicted smokers to quit.鈥 (Maloney, 6/21)
The headwinds are fierce. Tobacco companies have already indicated that any plan with significant reductions in nicotine would violate the law. And some conservative lawmakers might consider such a policy another example of government overreach, ammunition that could spill over into the midterm elections. (Jewett and Jacobs, 6/21)
The Biden administration says it is writing a plan that will order cigarette makers to cut cigarette nicotine levels to lower addiction. It is part of Biden鈥檚 plan to cut cancer deaths by 50% in 25 years. But don鈥檛 expect the order to take effect quickly 鈥 perhaps for years or maybe ever. First, there is the regulatory requirement that the Food and Drug Administration publishes the rule, invites public comments then publishes a final rule. Then, almost certainly, tobacco companies will sue to stop it. That could tie up the regulation for years. (Tompkins, 6/22)